Advances in Breast Cancer Research

Vol.9 No.2(2020), Paper ID 99421, 17 pages

DOI:10.4236/abcr.2020.92003

 

Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer

 

Salah Mabrouk Khallaf, Jasmine Roshdy, Abeer Ibrahim

 

Medical Oncology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt
Medical Oncology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt
Medical Oncology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt

 

Copyright © 2020 Salah Mabrouk Khallaf, Jasmine Roshdy, Abeer Ibrahim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Khallaf, S. , Roshdy, J. and Ibrahim, A. (2020) Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer. Advances in Breast Cancer Research, 9, 21-33. doi: 10.4236/abcr.2020.92003.

Copyright © 2025 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.